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By Máıra Aguiar
Weird times we are living in. While lots of
technological, medical and scientific advances
are generated in a short period of time, we are
now fighting a pandemic, trying to stop the
spread of a new virus that has not only killed
thousands of people but has also crippled our
economies as lockdowns were implemented.
In December 2019, a severe respiratory syn-
drome (COVID-19) caused by a new coron-
avirus (SARS-CoV-2), was identified in China
and spread rapidly around the globe. COVID-
19 was declared a pandemic by the World
Health Organization (WHO) in March, 2020.
As of this writing, about 25 million cases were
confirmed with more than 830 thousand deaths
- a global case fatality ratio (CFR) of approxi-
mately 3.5%.
COVID-19 symptoms can range from mild
(or no symptoms) to severe illness, with signs
and symptoms appearing between 2 to 14 days
after exposure. With many asymptomatic indi-
viduals, everyone is at risk of getting COVID-
19. SARS-CoV-2 infection results in dis-
ease severity and death according to a hierar-
chy of risks, with age and pre-existing health
conditions enhancing disease severity [1]. If
the young and “healthy” individuals are not
severely a↵ected, SARS-CoV-2 has put at a
greater risk our beloved parents and grandpar-
ents. An e↵ective vaccine would be the best
way to prevent COVID-19 infections and while
its development is ongoing, epidemiologists and
public health workers are the frontline of this
battle, fighting with well known public health
surveillance strategies of testing, contact trac-
ing and isolation of infected individuals.
While the global case fatality ratio (CFR),
a measure that is often used to evaluate the
severity of the epidemics, starts to decrease
over time, there are too many unknowns about
COVID-19 dynamics. Why do we observe so
di↵erent CFR in di↵erent countries around the
globe? Are there di↵erences in population sus-
ceptibility to SARS-CoV-2 infection and how
much would that a↵ect the course of infection
in the population? What is the influence of
seasonality on COVID-19 transmission? Would
it be enough to contain the epidemics, such
as other Influenza Like Illnesses (ILIs), even
when traveling restrictions start to be lifted and
imported cases from the southern hemisphere
would be likely to be detected? What is the
proportion and the role of the mild and asymp-
tomatic infected individuals? Are they trans-
mitting more or less than the symptomatic se-
vere infected? And to which extent the acquired
immunity and its duration against SARS-CoV-
2 will play a role in the so called herd immunity
without vaccination? Too many open questions
that scientists are trying to answer by labo-
ratory experiments, field work and theoretical
studies.
As the COVID-19 pandemic is unfolding, re-
search on mathematical modeling became im-
perative and very influential, not only in un-
derstanding the epidemiology of COVID-19 but
also in helping the national health systems to
cope with the high demands of hospitaliza-
tions, for example, providing projections and
predictions based on the available data. Used
as a public health guiding tool to evaluate
the impact of intervention measures, govern-
ments have already taken important decisions
based on modeling results. The COVID-19 pan-
demic has resulted in an avalanche of epidemi-
ological modeling papers [2, 3, 4, 5, 6, 7, 8],
most of them using simple models such as the
SIR (Susceptible-Infected- Recovered) or SEIR
(Susceptible-Exposed-Infected- Recovered) in
mechanistic or probabilistic frameworks to un-
derstand and predict the spread of the disease in
a population. With valuable results, modeling
the dynamics of COVID-19 is very challenging,
as we still know very little about the disease.
More complex models would be able to give
more accurate projections about specific vari-
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ables such as number of hospitalizations, inten-
sive care units admissions (ICUs) and deaths,
for example, over the course of the epidemics.
However, to build useful models, good quality
empirical data and its understanding, as well as
a close collaboration among mathematical mod-
elers, field and laboratory researchers as well as
public health stakeholders are essential.
Here I present my experience, as part of the
Basque Country Modeling Task Force (BMTF),
in monitoring the development of the COVID-
19 epidemic to assist the Basque Health Man-
agers and the Basque Government during the
lockdown lifting measures.
In March 2020, a multidisciplinary task force
was created to assist the Basque Health man-
agers and the Basque Government during the
COVID-19 responses. BMTF is a modeling
team, working on di↵erent approaches, includ-
ing stochastic processes, statistical methods
and artificial intelligence. The primary BMTF
objectives were to describe the epidemic in
terms of disease spreading and control in the
Basque Country and to give projections on
the national health system necessity during the
increased population demand on hospital ad-
missions. With a valid modeling framework,
we now monitor disease transmission when the
country lockdown was gradually lifted towards
the so called “new normality”.
We use stochastic SHARUCD-type models
(susceptible (S), severe cases prone to hospital-
ization (H), mild, sub-clinical or asymptomatic
(A), recovered (R), patients admitted to the in-
tensive care units (U) and the recorded cumu-
lative positive cases (C) which includes all new
positive cases for each class of H, A, U, R, and
deceased (D)) - an extension of the well known
simple SIR model. Epidemiological data used
to validate and parametrize the models are pro-
vided by the Basque Health Department and
the Basque Health Service (Osakidetza), con-
tinually collected with specific inclusion.
In our first modeling attempt, disease sever-
ity was decided upon infection with a propor-
tion ⌘ of infected individuals going to develop
severe symptoms prone to hospitalization or
(1 ⌘) to develop mild or no symptoms [9]. Mild
Figure 1: Ensemble of 200 stochastic realiza-
tions of the initial SHARUCD-model. Empir-
ical data are plotted as black/red dots. In a)
cumulative positive cases Icum(t), in b) cumu-
lative hospitalized cases CH(t), in c) cumulative
ICU admissions CU (t) and in d) cumulative de-
ceases casesD(t). The mean field solution with-
out control is shown as a blue line.
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Figure 2: Growth rates estimations for various
variables. In a) PCR positive cases (yellow),
hospitalizations (red) and ICU admission cases
(purple) and in b) growth rate for recovered
(green) and deceased cases (black) notified in
the Basque Country.
and asymptomatic individuals were assumed to
transmit the disease more e ciently (  , with
  > 1) than the severe cases which would be
first cases identified, at least at the beginning
of the pandemic when testing capacity was low.
In this approach, hospitalized cases could re-
cover, die or go to ICU, i.e., ICU was considered
a progression in severity of hospitalized cases.
Parameter insecurities were calculated numer-
ically with likelihood functions conditioned on
the others and the data from all 5 model vari-
ables and fixed as the model was able to de-
scribe the disease incidence during the exponen-
tial phase of the outbreak. Partial lockdown im-
plemented on March 16, 2020 was shown to de-
crease disease transmission in the Basque Coun-
try, with e↵ects observed on March 27, 2020,
well before the full lockdown on March 31, 2020.
The e↵ect of the disease control measures was
introduced using a standard sigmoid function
which was able to describe well the gradual
slowing down of the epidemic, see Fig. 1.
Figure 3: Ensemble of 200 stochastic real-
izations of the ICU refined SHARUCD-model.
Empirical data are plotted as black/red dots.
In a) cumulative positive cases Icum(t), in b)
cumulative hospitalized cases CH(t), in c) cu-
mulative ICU admissions CU (t) and in d) cu-
mulative deceases cases D(t). The mean field
solution without control is shown as a blue line.
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Analysis of the momentary reproduction ra-
tio and momentary growth rates [10] have
shown two groups of growth behaviour in re-
sponse to the lockdown measures. Synchro-
nization of the ICU admission cases with the
cumulative tested positive cases and hospital-
izations was observed, following the sigmoidal
function behaviour, and the deceased and re-
covered cases showing a delay in response to
the control measures of 8 to 10 days, see Fig. 2.
These findings have led to the first refine-
ment of our model, with the transition into ICU
admissions changed to a ratio, with infection
causing from asymptomatic up to very severe
cases. In good agreement, the refined model
can now describe well the hospitalizations, the
ICU admissions and the deceased cases (see Fig.
3), well matched within the median of the 200
stochastic realizations from the model [11]. Al-
though the cumulative incidences for tested pos-
itive cases could only be described qualitatively,
following the higher realizations range due to
the increasing testing capacities in the Basque
Country since March 22, 2020, we now work on
further model refinements evaluating the role of
seasonal e↵ect, the “new normality”after lock-
down lifting and the impact of imported cases
and increase testing capacity (see Fig. 4).
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ESMTB Thematic panels
The field of mathematical biology continues
to grow, and ESMTB has therefore decided to
foster interactions in subgroups, where society
members can meet and interact within more fo-
cused areas. Membership to the societys the-
matic panels is open to all members. New the-
matic panels may be formed by petition to the
ESMTB Board at any time.
Guidelines for the establishment and op-
eration of ESMTB thematic panels
The ESMTB welcomes the fostering of spe-
cialised interest groups among its members,
groups to be henceforth designated as the-
matic panels (name subject to discussion) to
inspire, advance and promote activities within
the scope of ESMTB. Thematic panels are or-
ganised within a certain theme and are hosted
by a chair. The following guidelines shall apply
to their establishment and operation.
1. Groups of at least 20 members may apply for
the establishment of a thematic panel with
the ESMTB board. Applications should be
sent to the ESMTB secretary and be signed
by the founding chair of the panel. A short
description of the scope and scientific in-
terests must be provided.
2. A liation to such panels is free of charge and
open to all interested members, who may
join in at any time. Membership in the
panel ends with the end of membership in
ESMTB.
3. The panel members will manage the oper-
ation of the panel on a democratic basis;
in particular, they nominate (or elect) the
chair in regular intervals. The chair is the
representative of the panel and serves as
the contact person for the ESMTB board.
When the chair changes, the secretary of
ESMTB should be informed as soon as pos-
sible.
4. ESMTBmay financially sponsor (if budget is
available) the activities of the panels, upon
request by the panel’s representative.
5. ESMTB expects each panel to produce peri-
odic summary documentation reporting on
the activities of the panel and indicating
likely directions of development in the re-
search area covered by the panel.
6. The ESMTB secretary is charged with facil-
itating panel operations and briefly report-
ing to the board on current developments.
7. ESMTB will host on the society’s webpage,
in the Newsletter, the Communications,
and social media news related to the ac-
tivities of the thematic panels, as provided
by the panel representatives.
8. Thematic groups and their members con-
sent the ESMTB to store and process their
names and contact data.
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